Clinical Trials Directory

Trials / Completed

CompletedNCT04865783

Cryospray to Reduce Pain During Venous Cannulation

Cryospray to Reduce Pain During Venous Cannulation - Randomized Placebo-controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
University of Southern Denmark · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial aims to evaluate if cryospray can reduce pain during intravenous cannulation in elective surgery compared to a placebo spray.

Detailed description

Venous cannulation is a common practice in the health care system. Before any procedure, intravenous access is always placed before induction of any anaesthesia. For many patients placement of a venous catheter is associated with pain and discomfort. Any quick and easy reduction in pain during the procedure is important for patients. Cryospray has been described as an easy-to-use supplement of analgesia to alleviate pain during intravenous access. Cryospray has been shown to reduce pain in venous cannulation in the emergency setting but not in the elective setting. A search in the literature reveals 2 recent metanalyses reporting 8 included trials and 11 included trials, respectively. Both metanalyses call for further research in relation to patients' satisfaction. By randomizing patients to either cryospray or placebo before venous cannulation, we hypothesize that cryospray reduces pain during venous cannulation compared to placebo.

Conditions

Interventions

TypeNameDescription
PROCEDURESaline sprayThe saline spray will be applied twice for 1-2 seconds.
PROCEDURECryosprayThe cryospray will be applied twice for 1-2 seconds.

Timeline

Start date
2021-05-25
Primary completion
2023-07-18
Completion
2023-07-18
First posted
2021-04-29
Last updated
2024-05-31

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04865783. Inclusion in this directory is not an endorsement.